Intravenous (IV) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Alessandro Gozzetti; Veronica Candi; Corrado Zuanelli Brambilla; Giulia Papini; Monica Bocchia
Author Information: Division of Haematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.